• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Projects
  • Funding
  • Research Data
  • Organizations
  • Researchers
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis.
 

Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis.

Options
  • Details
BORIS DOI
10.7892/boris.132211
Date of Publication
October 7, 2019
Publication Type
Article
Division/Institute

Universitätsklinik fü...

Institut für Sozial- ...

Contributor
Siontis, Georgios
Universitätsklinik für Kardiologie
Overtchouk, Pavel
Universitätsklinik für Kardiologie
Cahill, Thomas J
Modine, Thomas
Prendergast, Bernard
Praz, Fabien Daniel
Universitätsklinik für Kardiologie
Pilgrim, Thomas
Universitätsklinik für Kardiologie
Petrinic, Tatjana
Nikolakopoulou, Adriani
Institut für Sozial- und Präventivmedizin (ISPM)
Salanti, Georgiaorcid-logo
Institut für Sozial- und Präventivmedizin (ISPM)
Søndergaard, Lars
Verma, Subodh
Jüni, Peter
Windecker, Stephan
Universitätsklinik für Kardiologie
Subject(s)

600 - Technology::610...

300 - Social sciences...

Series
European Heart Journal
ISSN or ISBN (if monograph)
0195-668X
Publisher
Oxford University Press
Language
English
Publisher DOI
10.1093/eurheartj/ehz275
PubMed ID
31329852
Uncontrolled Keywords

Aortic stenosis Low s...

Description
AIMS 

Owing to new evidence from randomized controlled trials (RCTs) in low-risk patients with severe aortic stenosis, we compared the collective safety and efficacy of transcatheter aortic valve implantation (TAVI) vs. surgical aortic valve replacement (SAVR) across the entire spectrum of surgical risk patients.

METHODS AND RESULTS 

The meta-analysis is registered with PROSPERO (CRD42016037273). We identified RCTs comparing TAVI with SAVR in patients with severe aortic stenosis reporting at different follow-up periods. We extracted trial, patient, intervention, and outcome characteristics following predefined criteria. The primary outcome was all-cause mortality up to 2 years for the main analysis. Seven trials that randomly assigned 8020 participants to TAVI (4014 patients) and SAVR (4006 patients) were included. The combined mean STS score in the TAVI arm was 9.4%, 5.1%, and 2.0% for high-, intermediate-, and low surgical risk trials, respectively. Transcatheter aortic valve implantation was associated with a significant reduction of all-cause mortality compared to SAVR {hazard ratio [HR] 0.88 [95% confidence interval (CI) 0.78-0.99], P = 0.030}; an effect that was consistent across the entire spectrum of surgical risk (P-for-interaction = 0.410) and irrespective of type of transcatheter heart valve (THV) system (P-for-interaction = 0.674). Transcatheter aortic valve implantation resulted in lower risk of strokes [HR 0.81 (95% CI 0.68-0.98), P = 0.028]. Surgical aortic valve replacement was associated with a lower risk of major vascular complications [HR 1.99 (95% CI 1.34-2.93), P = 0.001] and permanent pacemaker implantations [HR 2.27 (95% CI 1.47-3.64), P < 0.001] compared to TAVI.

CONCLUSION 

Compared with SAVR, TAVI is associated with reduction in all-cause mortality and stroke up to 2 years irrespective of baseline surgical risk and type of THV system.
Handle
https://boris-portal.unibe.ch/handle/20.500.12422/181377
Show full item
File(s)
FileFile TypeFormatSizeLicensePublisher/Copright statementContent
Siontis EurHeartJ 2019.pdftextAdobe PDF1000.9 KBpublisherpublishedOpen
BORIS Portal
Bern Open Repository and Information System
Build: 396f6f [24.09. 11:22]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo